Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Debabrata Mohapatra, Aditya Kumar Gupta, Partha Haldar, Jagdish Prasad Meena, Pranay Tanwar & Rachna Seth. (2023) Efficacy and safety of vemurafenib in Langerhans cell histiocytosis (LCH): A systematic review and meta-analysis. Pediatric Hematology and Oncology 40:1, pages 86-97.
Read now
Read now
Arturo Bonometti. (2021) The triptych of mixed histiocytosis: a systematic review of 105 cases and proposed clinical classification. Leukemia & Lymphoma 62:1, pages 32-44.
Read now
Read now
Articles from other publishers (30)
Ashley V. Geerlinks & Oussama Abla. (2023) Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors. Pediatric Drugs 25:4, pages 399-409.
Crossref
Crossref
Jennifer Padwal, Lucia Baratto, Amit Chakraborty, Kristina Hawk, Sheri Spunt, Raffi Avedian & Heike E. Daldrup-Link. (2022) PET/MR of pediatric bone tumors: what the radiologist needs to know. Skeletal Radiology 52:3, pages 315-328.
Crossref
Crossref
Xue-min Gao, Jian Li & Xin-xin Cao. (2022) Signaling pathways, microenvironment, and targeted treatments in Langerhans cell histiocytosis. Cell Communication and Signaling 20:1.
Crossref
Crossref
Serhat ÇELİK, Zeynep Tuğba GÜVEN, Onur AŞIK, Muzaffer KEKLİK, Leylagül KAYNAR, Bülent ESER, Mustafa ÇETİN & Ali ÜNAL. (2022) Adult Onset Langerhans Cell Histiocytosis: A Single Center Experience. Medical Records.
Crossref
Crossref
Jacob J. Adashek, Arjun K. Menta, Neha K. Reddy, Aakash P. Desai, Jason Roszik & Vivek Subbiah. (2022) Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600–Mutant Tumors. Molecular Cancer Therapeutics 21:6, pages 871-878.
Crossref
Crossref
Menelaos Kanakis, Petros Petrou, Giota Lourida & Ilias Georgalas. (2022) Erdheim-Chester disease: a comprehensive review from the ophthalmologic perspective. Survey of Ophthalmology 67:2, pages 388-410.
Crossref
Crossref
Luis Carlos Salazar, Luz Ángela Moreno, Lina Eugenia Jaramillo & Edgar Vladimir Cabrera. (2021) Enfermedad de Erdheim-Chester: primer caso pediátrico reportado en Colombia. Biomédica 41:4, pages 615-624.
Crossref
Crossref
S. Menzinger, S. Fraitag & S. Barète. (2021) Histiocitosis. EMC - Dermatología 55:1, pages 1-16.
Crossref
Crossref
Suheyla Ocak, Zuhal Bayramoglu, Deniz Tugcu, Serap Karaman, Aysegul Unuvar & Zeynep Karakas. (2021) Mixed Langerhans Cell Histiocytosis and Erdheim-Chester Disease in a Girl: A Rare and Puzzling Diagnosis. Journal of Pediatric Hematology/Oncology 43:3, pages e375-e379.
Crossref
Crossref
Fanélie Jouenne, Amira Benattia & Abdellatif Tazi. (2021) Mitogen-activating protein kinase pathway alterations in Langerhans cell histiocytosis. Current Opinion in Oncology 33:2, pages 101-109.
Crossref
Crossref
Martin D. Hyrcza. 2021. Pediatric Head and Neck Textbook. Pediatric Head and Neck Textbook
83
97
.
Ozlem Tezol, Elvan Caglar Citak, Yavuz Selim Ayhan, Yuksel Balci, Zehra Pinar Koc & Yasemin Yuyucu Karabulut. (2020) Effective High-dose Interferon-α Therapy in a 13-Year-Old Girl With Erdheim-Chester Disease. Journal of Pediatric Hematology/Oncology 42:4, pages 326-331.
Crossref
Crossref
Albert Roessner, Maria Smolle & Johannes Haybäck. (2020) Riesenzelltumor des KnochensGiant cell tumor of bone. Der Pathologe 41:2, pages 134-142.
Crossref
Crossref
Huan Liu, Andrew R. Osterburg, Jennifer Flury, Zulma Swank, Dennis W. McGraw, Nishant Gupta, Kathryn A. Wikenheiser-Brokamp, Ashish Kumar, Abdellatif Tazi, Yoshikazu Inoue, Masaki Hirose, Francis X. McCormack & Michael T. Borchers. (2020) MAPK mutations and cigarette smoke promote the pathogenesis of pulmonary Langerhans cell histiocytosis. JCI Insight 5:4.
Crossref
Crossref
Alexander Averyanov, Evgeniya Kogan, Victor Lesnyak, Olesya Danilevskaya & Igor E. Stepanyan. 2020. Difficult to Diagnose Rare Diffuse Lung Disease. Difficult to Diagnose Rare Diffuse Lung Disease
321
359
.
Olive S. Eckstein, Johannes Visser, Carlos Rodriguez-Galindo & Carl E. Allen. (2019) Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition. Blood 133:15, pages 1691-1694.
Crossref
Crossref
Xiaolei Hao, Ruie Feng, Yalan Bi, Yuhan Liu, Chunde Li, Tao Lu & Yongji Tian. (2019) Dramatic efficacy of dabrafenib in Erdheim-Chester disease (ECD): a pediatric patient with multiple large intracranial ECD lesions hidden by refractory Langerhans cell histiocytosis. Journal of Neurosurgery: Pediatrics 23:1, pages 48-53.
Crossref
Crossref
Norbert Neckel, Andrej Lissat, Arendt von Stackelberg, Nadine Thieme, Mohemed-Salim Doueiri, Birgit Spors, Benedicta Beck-Broichsitter, Max Heiland & Jan-Dirk Raguse. (2019) Primary oral manifestation of Langerhans cell histiocytosis refractory to conventional therapy but susceptible to BRAF-specific treatment: a case report and review of the literature. Therapeutic Advances in Medical Oncology 11, pages 175883591987801.
Crossref
Crossref
Jiaoyang Cai, Xia Huang, Minzhi Yin, Ci Pan, Lili Song, Zhiyan Zhan, Jing Chen, Yijin Gao, Jingyan Tang, Yanxin Li & Shuhong Shen. (2019) A novel fusion gene PLEKHA6-NTRK3 in langerhans cell histiocytosis. International Journal of Cancer 144:1, pages 117-124.
Crossref
Crossref
Hany I. Sakr, Kaila Buckley, Robert Baiocchi, Weiqiang John Zhao & Jessica A. Hemminger. (2018) Erdheim Chester disease in a patient with Burkitt lymphoma: a case report and review of literature. Diagnostic Pathology 13:1.
Crossref
Crossref
Jaume Monmany, Esther Granell, Laura López & Pere Domingo. (2018) Resolved heart tamponade and controlled exophthalmos, facial pain and diabetes insipidus due to Erdheim-Chester disease. BMJ Case Reports, pages bcr-2018-225224.
Crossref
Crossref
José Manuel Fernández Armenteros, Nuria Arco Huguet, Veronica Sanmartin Novell, Felip Vilardell Villellas, Ana Velasco Sanchez, Elisa Martró Català, Rosa Maria Martí Laborda & Xavier Soria Gili. (2018) Langerhans cell histiocytosis mimicking molluscum contagiosum: A case series. Pediatric Blood & Cancer 65:7, pages e27047.
Crossref
Crossref
Noah A. Brown & Kojo S.J. Elenitoba-Johnson. (2018) Clinical implications of oncogenic mutations in pulmonary Langerhans cell histiocytosis. Current Opinion in Pulmonary Medicine 24:3, pages 281-286.
Crossref
Crossref
Joon Pyo Hong, Won Ki Ahn, Joo Yeon Lim, Jo Eun Jung, Seung Min Hahn, Jung Woo Han & Chuhl Joo Lyu. (2018) A Case of Erdheim-Chester Disease Developed during Treatment of Leukemiain a Child. Clinical Pediatric Hematology-Oncology 25:1, pages 66-70.
Crossref
Crossref
Regina Fölster-Holst. (2018) Differential diagnoses of diaper dermatitis. Pediatric Dermatology 35, pages s10-s18.
Crossref
Crossref
Gary Tran, Thy N. Huynh & Amy S. Paller. (2018) Langerhans cell histiocytosis: A neoplastic disorder driven by Ras-ERK pathway mutations. Journal of the American Academy of Dermatology 78:3, pages 579-590.e4.
Crossref
Crossref
Kathryn M. Wagner, Jacob J. Mandel, J. Clay Goodman, Shankar Gopinath & Akash J. Patel. (2018) Intracranial Erdheim-Chester Disease Mimicking Parafalcine Meningioma: Report of Two Cases and Review of the Literature. World Neurosurgery 110, pages 365-370.
Crossref
Crossref
Hamza Hashmi, Drew Murray, John Greenwell, Marwan Shaikh, Soumit Basu & Maxwell Krem. (2018) A Rare Case of Erdheim-Chester Disease (Non-Langerhans Cell Histiocytosis) with Concurrent Langerhans Cell Histiocytosis: A Diagnostic and Therapeutic Challenge. Case Reports in Hematology 2018, pages 1-6.
Crossref
Crossref
Zenggang Pan & Bette K Kleinschmidt-DeMasters. (2017) CNS Erdheim–Chester Disease: A Challenge to Diagnose. Journal of Neuropathology & Experimental Neurology 76:12, pages 986-996.
Crossref
Crossref
. (2017) Vemurafenib. Reactions Weekly 1648:1, pages 295-295.
Crossref
Crossref